New hope for tough breast cancer: experimental combo enters human testing
Disease control
Ongoing
This study is testing a new drug called azenosertib, combined with two existing cancer drugs, for people with advanced triple-negative breast cancer that has spread. The main goals are to find a safe dose and see if the combination makes tumors shrink. About 78 participants will …
Phase: PHASE1, PHASE2 • Sponsor: Filipa Lynce, MD • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC